Investor Center

Investor FAQs

Investor FAQs

Show All
Where is Beam Therapeutics’ corporate headquarters?
Beam Therapeutics is headquartered at 26 Landsdowne Street, Cambridge, MA 02139, U.S. The main phone number is (857) 327-8775.
When was the company founded?
Beam Therapeutics was founded and commenced operations in January 2017.
When did Beam Therapeutics go public?
Beam Therapeutics’ initial public offering (IPO) occurred on February 5, 2020.
When is Beam Therapeutics’ fiscal year-end?
Beam Therapeutics’ fiscal year ends on December 31st.
How is Beam Therapeutics’ stock traded?
Beam Therapeutics is traded on the NASDAQ Global Market under the ticker symbol BEAM.
Who is Beam Therapeutics’ transfer agent?
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1 800 962 4284
International Phone: +1 781 575 312
Who are Beam Therapeutics’ independent auditors?
Deloitte & Touche LLP
30 Rockefeller Plaza, 41st floor
New York, NY 10112-0015
Phone: +1 212 492 4000
Fax: +1 212 489 1687
Who is Beam Therapeutics’ legal counsel?
Ropes & Gray LLP
Prudential Tower
800 Boylston Street
Boston, MA 02199-3600
(617) 951-7000
Where can I get the latest corporate news releases and financial reports?
Beam Therapeutics’ press release archives can be viewed here.
How can I view documents Beam Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Beam Therapeutics’ SEC filings can be viewed here.
Whom should I contact if I have further questions?
You can submit queries to Beam Therapeutics’ investor relations department by contacting investors@beamtx.com.